Menu
Science and research

Professional Publications

Author
Title
Year of publication

Publications (3663)

[41]

Pagano, M.; Pepperkok, R.; Lukas, J.; Baldin, V.; Ansorge, W.; Bartek, J.; Draetta, G.

Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts

[year of publication 2006, impact factor 11.700]

[42]

Penicka, M.; Widimsky, P.; Kobylka, P.; Kozak, T.; Lang, O.

Early tissue distribution of bone marrow mononuclear cells after transcoronary transplantation in a patient with acute myocardial infarction.

[year of publication 2006, impact factor 11.632]

[43]

Von Lilienfeld-Toal, M.; Vehreschild, J.J.; Cornely, O.; Pagano, L.; Compagno, F.; Hirsch, H.H.; Pagliuca, A.; Akan, H.; Lagrou, K.; Hoenigl, M.; Klimko, N.; Verweij, P.; Duarte, R.; Zimmerli, S.; Bretagne, S.; Racil, Z.

Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases

[year of publication 2020, impact factor 11.528 ]

[44]

Machova Polakova, K.; Zizkova, H.; Zuna, J.; Motlova, E.; Hovorkova, L.; Gottschalk, A.; Glauche, I.; Koblihova, J.; Pecherkova, P.; Klamova, H.; Stastna Markova, M.; Srbova, D.; Benesova, A.; Polivkova, V.; et al.

Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission

[year of publication 2020, impact factor 11.528 ]

[45]

Polivkova, V.; Benesova, A.; Zizkova, H.; Koblihova, J.; Curik, N.; Motlova, E.; Klamova, H.; Salek, C.; Machova Polakova, K.

Sensitivity and reliability of DNA-based mutation analysis by allele-specific digital PCR to follow resistant BCR-ABL1-positive cells

[year of publication 2021, impact factor 11.528 ]

[46]

Lorentino, F.; Labopin, M.; Ciceri, F.; Vago, L.; Fleischhauer, K.; Afanasyev, B.; Kröger, N.; Cornelissen, J.J.; Lovira, M.; Meijer, E.; Vitek, A.; et al.

Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemia

[year of publication 2020, impact factor 11.528 ]

[47]

Hoeks, M.; Bagguley, T.; van Marrewijk, C.; Smith, A.; Bowen, D.; Culligan, D.; Kolade, S.; Symeonidis, A.; Garelius, H.; Spanoudakis, M.; Langemeijer, S.; Roelofs, R.; Wiegerinck, E.; Tatic, A.; Killick, S.; Panagiotidis, P.; Stanca, O.; Hellström-Lindberg, E.; Cermak, J.; et al.

Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome

[year of publication 2020, impact factor 11.528 ]

[48]

Hernández-Boluda, J.C.; Pereira, A.; Kröger, N.; Beelen, D.; Robin, M.; Bornhäuser, M.; Angelucci, E.; Vítek, A.; et al.

Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation

[year of publication 2020, impact factor 11.528 ]

[49]

Penicka, M.; Horak, J.; Kobylka, P.; Pytlik, R.; Kozak, T.; Belohlavek, O.; Lang, O.; Skalicka, H.; Simek, S.; Palecek, T.; Linhart, A.; Aschermann, M.; Widimsky, P.

Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction : a prematurely terminated randomized study

[year of publication 2008, impact factor 11.054]

[50]

Gilleece, M.H.; Shimoni, A.; Labopin, M.; Robinson, S.; Beelen, D.; Socié, G.; Unal, A.; Ganser, A.; Vitek, A.; Sengeloev, H.; Yakoub-Agha, I.; Tholouli, E.; Polge, E.; Mohty, M.; Nagler, A.

Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT

[year of publication 2021, impact factor 11.037 ]

[51]

Goodeve, A.C.; Eikenboom, J.; Castaman, G.; Rodeghiero, F.; Federici, A.B.; Batlle, J.; Meyer, D.; Mazurier, C.; Goudemand, J.; Schneppenheim, R.; Budde, U.; Ingerslev, J.; Habart, D.; Vorlova, Z.; et. al.

Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)

[year of publication 2012, impact factor 10.896 ]

[52]

Standeven, K.F.; Carter, A.M.; Grant, P.J.; Weisel, J.W.; Chernysh, I.; Masova, L.; Lord, S.T.; Ariens, R.A.S.

Functional analysis of fibrin gamma-chain cross-linking by activated factor XIII : determination of a cross-linking pattern that maximizes clot stiffness

[year of publication 2008, impact factor 10.896]

[53]

Malaspina, P.; Cruciani, F.; Ciminelli, B.M.; Terrenato, L.; Santolamazza, P.; Alonso, A.; Banyko, J.; Brdicka, R.; Garcia, O.; Gaudiano, C.; Guanti, G.; Kidd, K.K.; Lavinha, J.; Avila, M.; Mandich, P.; Moral, P.; Qamar, R.; Mehdi, S.Q.; Ragusa, A.; Stefanescu, G.; Caraghin, M.; Tyler-Smith, C.

Network analyses of Y-chromosomal types in Europe, Northern Africa, and Western Asia reveal specific patterns of geographic distribution

[year of publication 2006, impact factor 10.869]

[54]

Andre, P.; Hartwell, D.; Hrachovinova, I.; Saffaripour, S.; Wagner, D.D.

Pro-coagulant state resulting from high levels of soluble P-selectin in blood

[year of publication 2010, impact factor 10.789]

[55]

Lukas, J.; Petersen, B.O.; Holm, K.; Bartek, J.; Helin, K.

Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression

[year of publication 2006, impact factor 10.727]

[56]

Lukas, J.; Bartkova, J.; Bartek, J.

Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint

[year of publication 2006, impact factor 10.727]

[57]

Müller, H.; Lukáš, J.; Schneider, A.; Warthoe, P.; Bártek, J.; Eilers, M.; Strauss, M.

Cyclin-D1 expression is regulated by the retinoblastoma protein

[year of publication 2006, impact factor 10.667]

[58]

Satoh, T.; Satoh, H.; Iwahara, S.I.; Hrkal, Z.; Peyton, D.H.; Muller-Eberhard, U.

Roles of heme iron-coordinating histidine residues of human hemopexin expressed in baculovirus-infected insect cells

[year of publication 2006, impact factor 10.667]

[59]

Špringer, T.; Krejčík, Z.; Homola, J.

Detecting attomolar concentrations of microRNA related to myelodysplastic syndromes in blood plasma using a novel sandwich assay with nanoparticle release

[year of publication 2021, impact factor 10.618 ]

[60]

Peslova, G.; Petrak, J.; Kuzelova, K.; Hrdy, I.; Halada, P.; Kuchel, P.W.; Soe-Lin, S.; Ponka, P.; Sutak, R.; Becker, E.; Huang, M.L.-H.; Rahmato, Y.S.; Richardson, D.R.; Vyoral, D.

Hepcidin, the hormone of iron metabolism, is bound specifically to alpha-2-macroglobulin in blood

[year of publication 2009, impact factor 10.555]


Quick contact

Head of Science and Research Division
Tel:+420 221 977 305

Deputy head of Science and Research Division
Tel:+420 221 977 648

Secretary
Tel:+420 221 977 144


Opening hours

Ambulance
Mo – Fr: 7:00–18:00
Weekends: 9:00–13:00

Donors
Mo – Fr: 7:00–10:30

Visitors
Inpatient department
Mo – Fr: 13:00–18:00

ICU and Transplant unit
Mo – Fr: 14:00–17:00

How to find us

map

Ústav hematologie a krevní transfuze
(​Institute of Hematology and Blood Transfusion)

U Nemocnice 2094/1
128 00 Praha 2

The nearest underground station: Karlovo náměstí (line B)

The nearest tram station: Karlovo náměstí (10, 16, 22), Moráň (3, 6, 10, 16, 18, 24)

The nearest bus station: U Nemocnice (148), Karlovo náměstí (176)

How to get here